Who
Frazor Titus Edmondson III
Chief Legal Officer
Company insider
Files Form 4 as: Chief Legal Officer, Zai Lab.
In numbers
- Trades disclosed
- 113
- Buys
- 0
- Sells
- 21
- Bought
- $0
- Sold
- $3.6M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 1 Apr 2021
- Last trade
- 26 Jun 2026
- Last filed
- 29 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 26 Jun 2026filed 29 Jun 2026 | ZLAB Zai LabBiotechnology | SEC FORM 4 Sold | $72K4,103 at $17.46 | filing |
| 26 Jun 2026filed 29 Jun 2026 | ZLAB Zai LabBiotechnology | SEC FORM 4 Sold | $72K4,103 at $17.46 | filing |
| 25 Jun 2026filed 29 Jun 2026 | ZLAB Zai LabBiotechnology | SEC FORM 4 Code M | —14,600 | filing |
| 25 Jun 2026filed 29 Jun 2026 | ZLAB Zai Laboption or derivative · Biotechnology | SEC FORM 4 Code M | —14,600 at $0.00 | filing |
| 25 Jun 2026filed 29 Jun 2026 | ZLAB Zai Laboption or derivative · Biotechnology | SEC FORM 4 Code M | —14,600 at $0.00 | filing |
| 25 Jun 2026filed 29 Jun 2026 | ZLAB Zai LabBiotechnology | SEC FORM 4 Code M | —14,600 | filing |
| 14 May 2026filed 15 May 2026 | ZLAB Zai LabBiotechnology | SEC FORM 4 Sold | $71K3,517 at $20.19 | filing |
| 14 May 2026filed 15 May 2026 | ZLAB Zai LabBiotechnology | SEC FORM 4 Sold | $71K3,517 at $20.19 | filing |
| 6 Apr 2026filed 8 Apr 2026 | ZLAB Zai LabBiotechnology | SEC FORM 4 Sold | $25K1,224 at $20.45 | filing |
| 6 Apr 2026filed 8 Apr 2026 | ZLAB Zai LabBiotechnology | SEC FORM 4 Sold | $25K1,224 at $20.45 | filing |
| 2 Apr 2026filed 3 Apr 2026 | ZLAB Zai Laboption or derivative · Biotechnology | SEC FORM 4 Code M | —5,031 at $0.00 | filing |
| 2 Apr 2026filed 3 Apr 2026 | ZLAB Zai Laboption or derivative · Biotechnology | SEC FORM 4 Code M | —5,031 at $0.00 | filing |
| 2 Apr 2026filed 3 Apr 2026 | ZLAB Zai LabBiotechnology | SEC FORM 4 Code M | —5,031 | filing |
| 2 Apr 2026filed 3 Apr 2026 | ZLAB Zai LabBiotechnology | SEC FORM 4 Sold | $86K4,194 at $20.39 | filing |
| 2 Apr 2026filed 3 Apr 2026 | ZLAB Zai LabBiotechnology | SEC FORM 4 Code M | —5,031 | filing |
| 2 Apr 2026filed 3 Apr 2026 | ZLAB Zai LabBiotechnology | SEC FORM 4 Sold | $86K4,194 at $20.39 | filing |
| 1 Apr 2026filed 3 Apr 2026 | ZLAB Zai LabBiotechnology | SEC FORM 4 Code M | —2,671 | filing |
| 1 Apr 2026filed 3 Apr 2026 | ZLAB Zai LabBiotechnology | SEC FORM 4 Code M | —830 | filing |
| 1 Apr 2026filed 3 Apr 2026 | ZLAB Zai LabBiotechnology | SEC FORM 4 Code M | —13,758 | filing |
| 1 Apr 2026filed 3 Apr 2026 | ZLAB Zai Laboption or derivative · Biotechnology | SEC FORM 4 Code M | —2,671 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.